iTeos Therapeutics, Inc.: cash_and_restricted_cash
| Value | {"amount": 142430000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | iTeos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ce1e4c8d-f1a7-4d28-a710-70985ff20757
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-25-033066Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001808865/cash-and-restricted-cash/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ce1e4c8d-f1a7-4d28-a710-70985ff20757
History
- no predecessors — first report